Literature DB >> 18980576

Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF).

Antonio Pinto1, Antonino Tuttolomondo, Alessandra Casuccio, Domenico Di Raimondo, Riccardo Di Sciacca, Valentina Arnao, Giuseppe Licata.   

Abstract

The aim of the present study was to determine the rates of stroke in patients with chronic NVAF (non-valvular atrial fibrillation), evaluating the relationship between plasma levels of inflammatory variables at admission and the occurrence of stroke during a 3-year follow-up. A total of 373 consecutive patients with chronic NVAF were enrolled. Blood samples were drawn within 72 h of admission, and we evaluated plasma levels of IL (interleukin)-1beta, TNF-alpha (tumour necrosis factor-alpha), IL-6, IL-10, E-selectin, P-selectin, ICAM-1 (intercellular adhesion molecule-1), VCAM-1 (vascular cell adhesion molecule-1) and vWF (von Willebrand Factor). Subsequent patient events (stroke at follow-up) were monitored over a 3 year period. By multivariate analysis, only age, hypertension and high levels of IL-6, TNF-alpha and vWF remained significant predictors of a higher risk of experiencing ischaemic stroke at follow-up. Moreover, plasma values of TNF-alpha, IL-6 and vWF had a significant area under the ROC (receiver operating characteristic) curve. In conclusion, baseline plasma levels of TNF-alpha, IL-6 and vWF are predictors of new-onset ischaemic stroke at follow-up in patients with chronic NVAF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18980576     DOI: 10.1042/CS20080372

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  26 in total

1.  Significance of decreased serum interleukin-10 levels in the progression of cerebral infarction.

Authors:  Zeng-Yan Diao; Cui-Lan Wang; Hong-Shun Qi; Guo-Yong Jia; Chuan-Zhu Yan
Journal:  Clin Exp Med       Date:  2015-04-07       Impact factor: 3.984

Review 2.  Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes.

Authors:  Antonino Tuttolomondo; Carlo Maida; Antonio Pinto
Journal:  World J Orthop       Date:  2015-01-18

Review 3.  Role of inflammation in atrial fibrillation pathophysiology and management.

Authors:  Masahide Harada; David R Van Wagoner; Stanley Nattel
Journal:  Circ J       Date:  2015-02-16       Impact factor: 2.993

Review 4.  von Willebrand factor: an emerging target in stroke therapy.

Authors:  Simon F De Meyer; Guido Stoll; Denisa D Wagner; Christoph Kleinschnitz
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

5.  Inhibition of Peripheral TNF-α and Downregulation of Microglial Activation by Alpha-Lipoic Acid and Etanercept Protect Rat Brain Against Ischemic Stroke.

Authors:  Ming-Hsiu Wu; Chao-Ching Huang; Chung-Ching Chio; Kuen-Jer Tsai; Ching-Ping Chang; Nan-Kai Lin; Mao-Tsun Lin
Journal:  Mol Neurobiol       Date:  2015-09-15       Impact factor: 5.590

6.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

7.  Prognostic value of interleukin-6 in atrial fibrillation: A cohort study and meta-analysis.

Authors:  Xiaoyue Jia; Xi Cheng; Na Wu; Ying Xiang; Long Wu; Bin Xu; Chengying Li; Zhihui Zhang; Shifei Tong; Li Zhong; Yafei Li
Journal:  Anatol J Cardiol       Date:  2021-12       Impact factor: 1.596

8.  Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study.

Authors:  Amelia K Boehme; Leslie A McClure; Yu Zhang; Jorge M Luna; Oscar H Del Brutto; Oscar R Benavente; Mitchell S V Elkind
Journal:  Stroke       Date:  2016-03       Impact factor: 7.914

Review 9.  Von Willebrand Factor Plasma Levels Variability In Nonvalvular Atrial Fibrillation.

Authors:  Gerardo Muñoz Cortés; Martha Eva Viveros Sandoval; Carlos Arturo Areán Martínez; Helios Eduardo Vega Gómez; Sandra Edith López Castañeda; Anel Gómez García
Journal:  J Atr Fibrillation       Date:  2014-12-31

10.  Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.

Authors:  Karin Willeit; Raimund Pechlaner; Peter Willeit; Philipp Skroblin; Bernhard Paulweber; Christiana Schernthaner; Thomas Toell; Georg Egger; Siegfried Weger; Martin Oberhollenzer; Ludmilla Kedenko; Bernhard Iglseder; Enzo Bonora; Georg Schett; Manuel Mayr; Johann Willeit; Stefan Kiechl
Journal:  JAMA Cardiol       Date:  2017-05-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.